These results, together with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the principle of targeting ACKR3 as a novel technique to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases. We independently investigation, overview, and https://kirstenn516gwo8.scrappingwiki.com/user